EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

S‐Methyl Cysteine Sulfoxide Does Not Ameliorate Weight Gain or Hyperlipidemia in Mice Fed a High‐Fat Diet

Caroline R Hill iD, Armaghan Shafaei, Vance B Matthews, Natalie C Ward, Kevin D Croft, Joshua R Lewis, Jonathan M Hodgson, Lois Balmer, Lauren C Blekkenhorst

Molecular Nutrition & Food Research · 2024

DOI: 10.1002/mnfr.202400034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Caroline R Hill und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan Unive…. Hauptthemen laut MEDLINE: Diet, High-Fat, Mice, Inbred C57BL, Weight Gain, Hyperlipidemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Health and Medical Research Council of Australia Emerging Leadership Investigator Grant, National Heart Foundation of Australia Post-Doctoral Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope Higher intake of cruciferous and allium vegetables is associated with lower cardiometabolic risk. Little research has investigated the cardiometabolic effects of S‐methyl cysteine sulfoxide (SMCSO), found abundant in these vegetables. This study hypothesizes that SMCSO will blunt development of metabolic syndrome features in mice fed high‐fat feed. Methods and results Fifty C57BL/6 male mice are randomly assigned to standard‐chow, high‐fat, or high‐fat supplemented with low‐SMCSO (43 mg kg −1 body weight [BW] day −1 ), medium‐SMCSO (153 mg kg −1 BW day −1 ), or high‐SMCSO (256 mg kg −1 BW day −1 ) for 12‐weeks. High‐fat with SMCSO did not prevent diet‐induced obesity, glucose intolerance, or hypercholesterolemia. Mice fed high‐fat with SMCSO has higher hepatic lipids than mice fed standard‐chow or high‐fat alone. Urinary SMCSO increases at 6‐ and 12‐weeks in the low‐SMCSO group, before reducing 46% and 28% in the medium‐ and high‐SMCSO groups, respectively, at 12‐weeks, suggesting possible tissue saturation. Interestingly, two SMCSO‐fed groups consume significantly more feed, without significant weight gain. Due to limitations in measuring consumed feed, caution should be taken interpreting these results. Conclusion SMCSO (43–256 mg kg −1 BW day −1 ) does not ameliorate metabolic syndrome features in high‐fat fed mice. Substantial knowledge gaps remain. Further studies should administer SMCSO separately (i.e., gavage), with metabolic studies exploring tissue levels to better understand its physiological action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatMice, Inbred C57BLWeight GainHyperlipidemiasCysteineAnimalsMaleLiverObesityMiceMetabolic Syndrome

Stichwörter der Autor:innen

alliumbrassicametabolic syndromemethiinvegetables

Substanzen

Cysteine

Autor:innen und Institutionen

  • Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan University, Perth, Western Australia, 6000, Australia.
  • Centre for Integrative Metabolomics and Computational Biology, School of Science, Edith Cowan University, Joondalup, Australia, Western Australia, 6027.
  • Dobney Hypertension Centre, School of Biomedical Science, Royal Perth Hospital Unit, Royal Perth Hospital Medical Research Foundation, University of Western Australia, Perth, Western Australia, 6000, Australia.
  • Dobney Hypertension Centre, Medical School, Royal Perth Hospital Unit, Royal Perth Hospital Medical Research Foundation, University of Western Australia, Perth, Western Australia, 6000, Australia.
  • School of Biomedical Science, Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, 6000, Australia.
  • Medical School, University of Western Australia, Perth, Western Australia, 6000, Australia.

ORCID-Profile: Caroline R Hill

Förderung

  • Wellcome Trust
  • National Health and Medical Research Council of Australia Emerging Leadership Investigator Grant
  • National Heart Foundation of Australia Post-Doctoral Research Fellowship

Zitieren

APA

Hill, C. R., Shafaei, A., Matthews, V. B., Ward, N. C., Croft, K. D., Lewis, J. R., Hodgson, J. M., Balmer, L., & Blekkenhorst, L. C. (2024). S‐Methyl Cysteine Sulfoxide Does Not Ameliorate Weight Gain or Hyperlipidemia in Mice Fed a High‐Fat Diet. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202400034

Vancouver

Hill CR, Shafaei A, Matthews VB, Ward NC, Croft KD, Lewis JR, et al. S‐Methyl Cysteine Sulfoxide Does Not Ameliorate Weight Gain or Hyperlipidemia in Mice Fed a High‐Fat Diet. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202400034

BibTeX
@article{Hill2024,
  author = {Hill, Caroline R and Shafaei, Armaghan and Matthews, Vance B and Ward, Natalie C and Croft, Kevin D and Lewis, Joshua R and Hodgson, Jonathan M and Balmer, Lois and Blekkenhorst, Lauren C},
  title = {S‐Methyl Cysteine Sulfoxide Does Not Ameliorate Weight Gain or Hyperlipidemia in Mice Fed a High‐Fat Diet},
  journal = {Molecular Nutrition & Food Research},
  year = {2024},
  doi = {10.1002/mnfr.202400034}
}
Kostenlos starten →